Mankind Pharma Limited (MANKIND) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE634S01028
Key metrics
- Market Cap
- ₹97,323 Cr
- P/E Ratio
- 47.75
- EPS
- 49.35
- Book Value
- 401.16
- P/B Ratio
- 5.94
- ROE
- 11.55%
- ROCE
- 12.4%
- Debt / Equity
- 0.38
- Net Margin
- 13.4%
- Revenue Growth
- 16.96%
- Profit Growth
- -3.92%
- Dividend Yield
- 0.08%
- 52W High
- ₹2,674.00
- 52W Low
- ₹1,909.70
- Market Cap Band
- large cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About Mankind Pharma Limited
Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, urology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory, and other diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. In addition, the company engages in the trading of pharmaceutical and health care products; manufacture of packing materials, ayurvedic products, and consumer goods; real estate, leasing, and hospitality businesses; trading of agricultural and pet food products; and provision of IT services. It offers its products under the Manforce, Moxi Kind-Cv, AmLokind-At, Unwanted-Kit, Prega News, Dydroboon, Telmikind-Am, Gudcef, Glimestar-M, Candi Force, Nurokind-Gold, Telmikind-H, Telmikind, Nurokind-Lc, Nurokind Plus-Rf, Vomikind, Cefakind, Glizid-M, Monticope, and Gudcef-Cv brand names. Mankind Pharma Limited was incorporated in 1991 and is based in New Delhi, India.
- Headquarters
- New Delhi, India
- Employees
- 20,451
- Promoter Holding
- 75.4%
The full Mankind Pharma Limited analysis
Create a free account to open the complete MANKIND deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.